Polysorbate 80 coated chitosan nanoparticles for delivery of α-melanocyte stimulating hormone analog (NDP-MSH) to the brain reverse cognitive impairment related to neuroinflammation produced by a high-fat diet (HFD).
Polysorbate 80-coated chitosan nanoparticles may improve the delivery of NDP-MSH to the brain, potentially addressing cognitive impairments related to high-fat diets in rats.
Where it sits
this study against the rest of the melanotan 1 corpusSummary and findings
This study investigated the use of polysorbate 80-coated chitosan nanoparticles for delivering α-Melanocyte Stimulating Hormone analog (NDP-MSH) to the brain in a rat model. The nanoparticles were shown to cross the blood-brain barrier and accumulate in CA1 neurons within 2 hours. Cognitive impairments related to neuroinflammation from a high-fat diet were assessed in male Wistar rats over two experimental models.
Abstract
This study aimed to develop polysorbate 80-coated chitosan nanoparticles (PS80/CS NPs) as a delivery system for improved brain targeting of α-Melanocyte Stimulating Hormone analog (NDP-MSH). Chitosan nanoparticles loaded with NDP-MSH were surface-modified with polysorbate 80 ([NDP-MSH]-PS80/CS NP), which formed a flattened layer on their surface. Nanoparticle preparation involved ionic gelation, followed by characterization using scanning electron microscopy (SEM) for morphology, dynamic light scattering (DLS) for colloidal properties, and ATR-FTIR spectroscopy for structure. Intraperitoneal injection of FITC-PS80/CS NPs and [NDP-MSH]-PS80/CS NP in rats demonstrated their ability to cross the blood-brain barrier, reach the brain, and accumulate in CA1 neurons of the dorsal hippocampus within 2 h. Two experimental models of neuroinflammation were employed with Male Wistar rats: a short-term model involving high-fat diet (HFD) consumption for 5 days followed by an immune stimulus with LPS, and a long-term model involving HFD consumption for 8 weeks. In both models, [NDP-MSH]-PS80/CS NPs could reverse the decreased expression of contextual fear memory induced by the diets. These findings suggest that [NDP-MSH]-PS80/CS NPs offer a promising strategy to overcome the limitations of NDP-MSH regarding pharmacokinetics and enzymatic stability. By facilitating NDP-MSH delivery to the hippocampus, these nanoparticles can potentially mitigate the cognitive impairments associated with HFD consumption and neuroinflammation.
Background
The paper addresses cognitive impairment associated with neuroinflammation due to high-fat diets, a growing concern in metabolic and neurodegenerative disorders. Prior studies have indicated that α-melanocyte stimulating hormone (α-MSH) may have neuroprotective effects, but the delivery mechanisms and efficacy in reversing cognitive deficits remain unclear. This study aims to explore a novel delivery system using nanoparticles to enhance the bioavailability of NDP-MSH in the brain.
Methods
The study utilized a rodent model to assess the cognitive effects of NDP-MSH delivered via polysorbate 80 coated chitosan nanoparticles. The sample size, specific dosing regimen, and duration of treatment were not reported in the abstract. Primary outcomes included measures of cognitive function and markers of neuroinflammation.
Results
Not reported in abstract.
Interpretation
Without specific results reported, it is challenging to compare this study's findings to existing literature on NDP-MSH and cognitive function. The potential for nanoparticles to enhance delivery to the brain could represent a significant advancement, but without clear data on effect sizes or clinical relevance, conclusions remain speculative. Confounding factors such as the model used and the lack of human data limit the applicability of these findings to clinical practice.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.